AGADA Biosciences Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

AGADA Biosciences General Information

Description

Developer of orphan drug development platform designed for neuromuscular disorders. The company's service includes centralized preclinical drug efficacy testing and phenotyping services for neuromuscular disorders, with specific expertise in murine models of Duchenne muscular dystrophy, enabling companies to provide normative values and benchmarking in multiple murine models of neuromuscular disease.

Contact Information

Website
www.agadabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • FOH-115 1489 Hollis Street
  • Halifax, Nova Scotia B3J 3M5
  • Canada
+1 (902)
Primary Industry
Clinics/Outpatient Services
Other Industries
Drug Discovery
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • FOH-115 1489 Hollis Street
  • Halifax, Nova Scotia B3J 3M5
  • Canada
+1 (902)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AGADA Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Dec-2022 Completed Generating Revenue
4. Grant 08-Jul-2019 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
2. Accelerator/Incubator 21-Oct-2014 $23.4K $23.4K Completed Startup
1. Accelerator/Incubator Completed Startup
To view AGADA Biosciences’s complete valuation and funding history, request access »

AGADA Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AGADA Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Invest Nova Scotia Venture Capital Minority
Duchenne UK Corporation
Life Sciences Nova Scotia Accelerator/Incubator
Global Business Accelerator Accelerator/Incubator
To view AGADA Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial

AGADA Biosciences FAQs

  • When was AGADA Biosciences founded?

    AGADA Biosciences was founded in 2013.

  • Where is AGADA Biosciences headquartered?

    AGADA Biosciences is headquartered in Halifax, Canada.

  • What is the size of AGADA Biosciences?

    AGADA Biosciences has 20 total employees.

  • What industry is AGADA Biosciences in?

    AGADA Biosciences’s primary industry is Clinics/Outpatient Services.

  • Is AGADA Biosciences a private or public company?

    AGADA Biosciences is a Private company.

  • What is AGADA Biosciences’s current revenue?

    The current revenue for AGADA Biosciences is .

  • How much funding has AGADA Biosciences raised over time?

    AGADA Biosciences has raised $23.4K.

  • Who are AGADA Biosciences’s investors?

    Invest Nova Scotia, Duchenne UK, Life Sciences Nova Scotia, and Global Business Accelerator have invested in AGADA Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »